how good.. Regal huge loss this financial year.. funds under management will tank.. hasty sale of positions post a 100% wipe out on OPT proving their whole investment strategy is shakey... and the best part - cheap stock for me.
- Forums
- ASX - By Stock
- MSB
- Ann: Meeting Requested with FDA on Revascor Accelerated Approval
MSB
mesoblast limited
Add to My Watchlist
2.47%
!
$1.78

Ann: Meeting Requested with FDA on Revascor Accelerated Approval, page-22
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.78 |
Change
-0.045(2.47%) |
Mkt cap ! $2.280B |
Open | High | Low | Value | Volume |
$1.80 | $1.83 | $1.76 | $7.268M | 4.070M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 21597 | $1.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.79 | 49625 | 67 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 23468 | 1.780 |
20 | 36061 | 1.775 |
12 | 27587 | 1.770 |
14 | 108043 | 1.765 |
12 | 79592 | 1.760 |
Price($) | Vol. | No. |
---|---|---|
1.785 | 41087 | 61 |
1.790 | 18553 | 19 |
1.795 | 21073 | 10 |
1.800 | 100159 | 19 |
1.805 | 95783 | 8 |
Last trade - 13.17pm 18/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online